Substituted 1h-pyrrolo[2,3-b]pyridin-3-yl] compound
PK141484AUndetermined Publication Date: 2012-10-17NOVARTIS AG
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- NOVARTIS AG
- Publication Date
- 2012-10-17
Abstract
There is provided according to the invention a compound selected from: [2-Methyl-l -(2-trifluoromethyl-benzyl)-1 H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; [4-Chloro-1-(4-methanesulfonyl-benzyl)-2-methyl-1 H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid: [1-(2-Chloro-4-methanesulfonyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; [1-(4-Elhanesulfonyl-2-trifluorom ethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yll-acetic acid; [1-(2-Chloro-4-ethanesulfonyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; [1-(4-Methanesulfonyl-2-trifluorom ethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; 1-(4-Methanesulfpnyl-benzyl)-2-methyl-1Hpyrrolo[2,3-b]pyridin-3-yl]-acetic acid; {1-[1-(4^-Methanesulfonyl-phenyl)-ethyl]-2methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-acetic acid; [6-Chloro-1-(4-methanesulfonyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; [6-Chloro-1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; [1-(3-Chloro-4-methanesulfonyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; and [1-(3-Fluoro-4-methanesulfonyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid; and a pharmaceutical composition comprising thereof.
Need to check novelty before this filing date? Find Prior Art